$SPRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GUIDED THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GUIDED THERAPEUTICS INC. Get notifications about new insider transactions in GUIDED THERAPEUTICS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | Cartwright Gene S | President & CEO | Option Exercise | P | 0.09 | 117,780 | 10,600 | 117,780 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | Cartwright Gene S | President & CEO | Option Exercise | P | 0.11 | 117,870 | 12,966 | 117,780 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | Cartwright Gene S | President & CEO | Buy | P | 0.12 | 37,504 | 4,500 | 2,235,739 | 2.2 M to 2.2 M (+1.71 %) |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | P | 0.09 | 189,889 | 17,090 | 189,889 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | P | 0.10 | 18,382 | 1,912 | 18,382 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | S | 0.10 | 189,889 | 19,748 | 0 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | S | 1.08 | 18,382 | 19,853 | 0 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | A | 0.10 | 600,000 | 60,000 | 1,255,000 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Buy | P | 0.00 | 5,682 | 0 | 696,748 | 691.1 K to 696.7 K (+0.82 %) |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | P | 0.09 | 58,935 | 5,304 | 58,935 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | P | 0.11 | 58,935 | 6,483 | 58,935 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | S | 0.23 | 58,935 | 13,260 | 0 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | P | 0.09 | 3,797,789 | 341,801 | 3,797,789 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | P | 0.10 | 367,647 | 38,235 | 367,647 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | S | 0.10 | 3,797,789 | 394,970 | 0 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | S | 1.08 | 367,647 | 397,059 | 0 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | A | 0.10 | 600,000 | 60,000 | 600,000 | |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Grant | A | 0.00 | 113,636 | 0 | 9,885,973 | 9.8 M to 9.9 M (+1.16 %) |
| Jul 17 2015 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Buy | P | 0.00 | 18,752 | 0 | 9,904,725 | 9.9 M to 9.9 M (+0.19 %) |
| Apr 10 2015 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Buy | S | 0.16 | 3,906 | 625 | 691,066 | 687.2 K to 691.1 K (+0.57 %) |
| Apr 10 2015 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Grant | A | 0.16 | 78,125 | 12,500 | 9,772,337 | 9.7 M to 9.8 M (+0.81 %) |
| Jan 16 2015 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Grant | A | 0.23 | 54,348 | 12,500 | 9,694,212 | 9.6 M to 9.7 M (+0.56 %) |
| Jan 16 2015 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Buy | S | 0.23 | 2,717 | 625 | 687,160 | 684.4 K to 687.2 K (+0.40 %) |
| Dec 09 2014 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | J | 0.23 | 58,965 | 13,267 | 58,965 | |
| Dec 09 2014 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Buy | P | 0.23 | 117,870 | 26,521 | 9,639,864 | 9.5 M to 9.6 M (+1.24 %) |
| Dec 09 2014 | SPRX | GUIDED THERAPEUTIC ... | Cartwright Gene S | PRESIDENT & CEO | Option Exercise | J | 0.23 | 117,870 | 26,521 | 117,870 | |
| Dec 09 2014 | SPRX | GUIDED THERAPEUTIC ... | Cartwright Gene S | PRESIDENT & CEO | Buy | J | 0.23 | 235,739 | 53,041 | 2,335,739 | 2.1 M to 2.3 M (+11.23 %) |
| Oct 21 2014 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Buy | S | 0.32 | 1,953 | 625 | 1,313,154 | 1.3 M to 1.3 M (+0.15 %) |
| Oct 21 2014 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Grant | A | 0.32 | 39,063 | 12,500 | 9,521,994 | 9.5 M to 9.5 M (+0.41 %) |
| Aug 20 2014 | SPRX | GUIDED THERAPEUTIC ... | Niloff Jonathan M | Director | Grant | A | 0.46 | 152,174 | 70,000 | 339,466 | 187.3 K to 339.5 K (+81.25 %) |
| Aug 20 2014 | SPRX | GUIDED THERAPEUTIC ... | ROSENSTOCK LINDA | Director | Grant | A | 0.46 | 152,174 | 70,000 | 287,174 | 135 K to 287.2 K (+112.72 %) |
| Aug 20 2014 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Grant | A | 0.46 | 152,174 | 70,000 | 1,311,201 | 1.2 M to 1.3 M (+13.13 %) |
| Aug 20 2014 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Grant | A | 0.46 | 152,174 | 70,000 | 9,416,963 | 9.3 M to 9.4 M (+1.64 %) |
| Jul 08 2014 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Sell | S | 0.50 | 7,500 | 3,750 | 1,159,027 | 1.2 M to 1.2 M (-0.64 %) |
| Jun 26 2014 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Sell | D | 0.50 | 12,500 | 6,250 | 1,166,527 | 1.2 M to 1.2 M (-1.06 %) |
| Jun 20 2014 | SPRX | GUIDED THERAPEUTIC ... | Cartwright Gene S | PRESIDENT & CEO | Buy | P | 0.49 | 26,000 | 12,636 | 2,050,000 | 2 M to 2.1 M (+1.28 %) |
| Jun 20 2014 | SPRX | GUIDED THERAPEUTIC ... | Cartwright Gene S | PRESIDENT & CEO | Buy | P | 0.48 | 23,000 | 11,086 | 2,073,000 | 2.1 M to 2.1 M (+1.12 %) |
| Jun 20 2014 | SPRX | GUIDED THERAPEUTIC ... | Cartwright Gene S | PRESIDENT & CEO | Buy | P | 0.49 | 27,000 | 13,122 | 2,100,000 | 2.1 M to 2.1 M (+1.30 %) |
| Jun 20 2014 | SPRX | GUIDED THERAPEUTIC ... | Cartwright Gene S | PRESIDENT & CEO | Buy | P | 0.49 | 26,000 | 12,636 | 2,050,000 | 2 M to 2.1 M (+1.28 %) |
| Jun 20 2014 | SPRX | GUIDED THERAPEUTIC ... | Cartwright Gene S | PRESIDENT & CEO | Buy | P | 0.48 | 23,000 | 11,086 | 2,073,000 | 2.1 M to 2.1 M (+1.12 %) |
| Jun 20 2014 | SPRX | GUIDED THERAPEUTIC ... | Cartwright Gene S | PRESIDENT & CEO | Buy | P | 0.49 | 27,000 | 13,122 | 2,100,000 | 2.1 M to 2.1 M (+1.30 %) |
| Jun 18 2014 | SPRX | GUIDED THERAPEUTIC ... | Cartwright Gene S | Chief Executive Off ... | Buy | P | 0.49 | 24,000 | 11,714 | 2,024,000 | 2 M to 2 M (+1.20 %) |
| Jun 02 2014 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Sell | S | 0.50 | 12,500 | 6,250 | 1,179,027 | 1.2 M to 1.2 M (-1.05 %) |
| Jun 03 2014 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Sell | S | 0.50 | 12,500 | 6,250 | 1,166,527 | 1.2 M to 1.2 M (-1.06 %) |
| Feb 07 2014 | SPRX | GUIDED THERAPEUTIC ... | Cartwright Gene S | Chief Executive Off ... | Grant | A | 0.00 | 2,000,000 | 0 | 2,000,000 | 0 to 2 M |
| Dec 05 2013 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | M | 0.40 | 1,466,420 | 586,568 | 0 | |
| Dec 05 2013 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | A | 0.40 | 1,466,420 | 586,568 | 1,466,420 | |
| Dec 05 2013 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | D | 0.65 | 1,446,420 | 940,173 | 0 | |
| Dec 05 2013 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Buy | M | 0.40 | 1,466,420 | 586,568 | 9,264,789 | 7.8 M to 9.3 M (+18.80 %) |
| Dec 05 2013 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Option Exercise | A | 0.40 | 58,333 | 23,333 | 58,333 | |
| Dec 05 2013 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Grant | A | 0.40 | 58,333 | 23,333 | 381,668 | 323.3 K to 381.7 K (+18.04 %) |
| Jul 29 2013 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | D | 0.65 | 128,221 | 83,344 | 3,796,354 | |
| Jul 29 2013 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Buy | M | 0.65 | 128,221 | 83,344 | 7,798,369 | 7.7 M to 7.8 M (+1.67 %) |
| May 24 2013 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | P | 1.08 | 18,383 | 19,854 | 18,383 | |
| May 24 2013 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | P | 1.08 | 18,382 | 19,853 | 18,382 | |
| May 24 2013 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | P | 0.68 | 25 | 17 | 25 | |
| May 28 2013 | SPRX | GUIDED THERAPEUTIC ... | Landegger George F | 10% Owner | Option Exercise | P | 1.08 | 73,530 | 79,412 | 73,530 | |
| May 28 2013 | SPRX | GUIDED THERAPEUTIC ... | Landegger George F | 10% Owner | Option Exercise | P | 1.08 | 73,529 | 79,411 | 73,529 | |
| May 28 2013 | SPRX | GUIDED THERAPEUTIC ... | Landegger George F | 10% Owner | Option Exercise | P | 0.68 | 100 | 68 | 100 | |
| May 24 2013 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | P | 1.08 | 367,647 | 397,059 | 367,647 | |
| May 24 2013 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | P | 1.08 | 367,647 | 397,059 | 367,647 | |
| May 24 2013 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | P | 0.68 | 500 | 340 | 500 | |
| Apr 09 2013 | SPRX | GUIDED THERAPEUTIC ... | FAUPEL MARK L | President & CEO | Option Exercise | A | 0.67 | 35,000 | 23,450 | 35,000 | |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Option Exercise | A | 0.69 | 25,000 | 17,250 | 25,000 | |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Option Exercise | A | 0.69 | 31,250 | 21,563 | 31,250 | |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Grant | A | 0.00 | 73,125 | 0 | 323,335 | 250.2 K to 323.3 K (+29.23 %) |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | ROSENSTOCK LINDA | Director | Option Exercise | A | 0.69 | 18,750 | 12,938 | 18,750 | |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | ROSENSTOCK LINDA | Director | Option Exercise | A | 0.69 | 31,250 | 21,563 | 31,250 | |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | ROSENSTOCK LINDA | Director | Grant | A | 0.00 | 135,000 | 0 | 135,000 | 0 to 135 K |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | A | 0.69 | 25,000 | 17,250 | 25,000 | |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | A | 0.69 | 31,250 | 21,563 | 31,250 | |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Grant | A | 0.00 | 78,750 | 0 | 7,670,148 | 7.6 M to 7.7 M (+1.04 %) |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | Niloff Jonathan M | Director | Option Exercise | A | 0.69 | 25,000 | 17,250 | 25,000 | |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | Niloff Jonathan M | Director | Option Exercise | A | 0.69 | 31,250 | 21,563 | 31,250 | |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | Niloff Jonathan M | Director | Grant | A | 0.00 | 148,125 | 0 | 187,292 | 39.2 K to 187.3 K (+378.19 %) |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | A | 0.80 | 25,000 | 20,000 | 25,000 | |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | A | 0.69 | 31,250 | 21,563 | 31,250 | |
| Apr 02 2013 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Grant | A | 0.00 | 150,938 | 0 | 1,127,017 | 976.1 K to 1.1 M (+15.46 %) |
| Aug 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.71 | 10,000 | 7,100 | 348,368 | 358.4 K to 348.4 K (-2.79 %) |
| Aug 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.71 | 12,500 | 8,875 | 358,368 | 370.9 K to 358.4 K (-3.37 %) |
| Aug 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 10,000 | 7,000 | 370,868 | 380.9 K to 370.9 K (-2.63 %) |
| Aug 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.73 | 2,500 | 1,828 | 380,868 | 383.4 K to 380.9 K (-0.65 %) |
| Aug 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.84 | 1,000 | 840 | 383,368 | 384.4 K to 383.4 K (-0.26 %) |
| Aug 23 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 11,500 | 9,775 | 384,368 | 395.9 K to 384.4 K (-2.91 %) |
| Aug 10 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.84 | 6,500 | 5,460 | 395,868 | 402.4 K to 395.9 K (-1.62 %) |
| Aug 10 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 6,000 | 5,100 | 402,368 | 408.4 K to 402.4 K (-1.47 %) |
| Aug 09 2012 | SPRX | GUIDED THERAPEUTIC ... | FAUPEL MARK L | CEO | Grant | A | 0.65 | 153,846 | 100,000 | 253,846 | 100 K to 253.8 K (+153.85 %) |
| Aug 09 2012 | SPRX | GUIDED THERAPEUTIC ... | FAUPEL MARK L | CEO | Grant | A | 0.79 | 13,630 | 10,768 | 267,476 | 253.8 K to 267.5 K (+5.37 %) |
| Aug 09 2012 | SPRX | GUIDED THERAPEUTIC ... | FOWLER RICHARD | V.P. Engineering | Grant | A | 0.79 | 10,892 | 8,605 | 98,115 | 87.2 K to 98.1 K (+12.49 %) |
| Aug 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.90 | 4,600 | 4,140 | 408,368 | 413 K to 408.4 K (-1.11 %) |
| Aug 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.93 | 100 | 93 | 412,968 | 413.1 K to 413 K (-0.02 %) |
| Aug 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.94 | 7,560 | 7,106 | 413,068 | 420.6 K to 413.1 K (-1.80 %) |
| Aug 03 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.95 | 240 | 228 | 420,628 | 420.9 K to 420.6 K (-0.06 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | A | 0.85 | 54,429 | 46,265 | 1,736,574 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | A | 0.65 | 54,429 | 35,379 | 1,682,145 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | A | 0.00 | 54,430 | 0 | 1,627,716 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | A | 0.85 | 51,282 | 43,590 | 1,573,286 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | A | 0.65 | 51,282 | 33,333 | 1,522,004 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | A | 0.00 | 51,282 | 0 | 1,470,722 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | D | 0.65 | 163,288 | 106,137 | 1,419,440 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Option Exercise | D | 0.65 | 153,846 | 100,000 | 1,582,728 | |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.85 | 12,500 | 10,625 | 420,868 | 433.4 K to 420.9 K (-2.88 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 3,300 | 2,274 | 433,368 | 436.7 K to 433.4 K (-0.76 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 9,700 | 6,693 | 436,668 | 446.4 K to 436.7 K (-2.17 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 5,300 | 3,657 | 446,368 | 451.7 K to 446.4 K (-1.17 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.60 | 3,100 | 1,860 | 451,668 | 454.8 K to 451.7 K (-0.68 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 1,100 | 770 | 454,768 | 455.9 K to 454.8 K (-0.24 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.71 | 2,500 | 1,763 | 455,868 | 458.4 K to 455.9 K (-0.55 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 12,500 | 9,500 | 458,368 | 470.9 K to 458.4 K (-2.65 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.65 | 6,500 | 4,225 | 470,868 | 477.4 K to 470.9 K (-1.36 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.68 | 7,565 | 5,106 | 477,368 | 484.9 K to 477.4 K (-1.56 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.68 | 1,935 | 1,316 | 484,933 | 486.9 K to 484.9 K (-0.40 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 1,500 | 1,035 | 486,868 | 488.4 K to 486.9 K (-0.31 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.69 | 1,000 | 690 | 488,368 | 489.4 K to 488.4 K (-0.20 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.70 | 5,500 | 3,850 | 489,368 | 494.9 K to 489.4 K (-1.11 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 5,500 | 4,125 | 494,868 | 500.4 K to 494.9 K (-1.10 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 500 | 380 | 500,368 | 500.9 K to 500.4 K (-0.10 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.75 | 4,000 | 3,000 | 500,868 | 504.9 K to 500.9 K (-0.79 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.76 | 3,500 | 2,660 | 504,868 | 508.4 K to 504.9 K (-0.69 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 5,000 | 3,850 | 508,368 | 513.4 K to 508.4 K (-0.97 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.77 | 12,500 | 9,625 | 513,368 | 525.9 K to 513.4 K (-2.38 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.62 | 10,000 | 6,200 | 525,868 | 535.9 K to 525.9 K (-1.87 %) |
| Aug 01 2012 | SPRX | GUIDED THERAPEUTIC ... | JAMES MICHAEL C | Director | Sell | D | 0.65 | 2,500 | 1,625 | 535,868 | 538.4 K to 535.9 K (-0.46 %) |
| Jul 16 2012 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | D | 0.40 | 1,466,420 | 586,568 | 3,317,503 | |
| Jul 16 2012 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | D | 0.40 | 128,221 | 51,288 | 3,189,282 | |
| Jul 16 2012 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Buy | M | 0.40 | 1,594,641 | 637,856 | 7,591,398 | 6 M to 7.6 M (+26.59 %) |
| Jul 09 2012 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | A | 0.80 | 1,466,420 | 1,173,136 | 1,466,420 | |
| Jul 09 2012 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | A | 0.65 | 1,466,420 | 953,173 | 2,932,840 | |
| Jul 09 2012 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | A | 0.00 | 1,466,420 | 0 | 4,399,260 | |
| Jul 09 2012 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | A | 0.80 | 128,221 | 102,577 | 4,527,481 | |
| Jul 09 2012 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | A | 0.65 | 128,221 | 83,344 | 4,655,702 | |
| Jul 09 2012 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | A | 0.00 | 128,221 | 0 | 4,783,923 | |
| Jul 09 2012 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | D | 0.65 | 384,663 | 250,031 | 4,399,260 | |
| Jul 09 2012 | SPRX | GUIDED THERAPEUTIC ... | Imhoff John E | Director | Option Exercise | D | 0.65 | 4,399,260 | 2,859,519 | 0 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | M | 0.40 | 51,282 | 20,513 | 0 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | M | 0.40 | 21,522 | 8,609 | 0 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | A | 0.80 | 51,282 | 41,026 | 51,282 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | A | 0.65 | 51,282 | 33,333 | 51,282 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | A | 0.00 | 51,282 | 0 | 51,282 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | A | 0.80 | 21,520 | 17,216 | 21,520 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | A | 0.65 | 21,522 | 13,989 | 21,522 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | A | 0.00 | 21,522 | 0 | 21,522 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | D | 0.65 | 153,846 | 100,000 | 0 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Option Exercise | D | 0.65 | 64,564 | 41,967 | 0 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Buy | M | 0.40 | 57,282 | 22,913 | 265,019 | 207.7 K to 265 K (+27.57 %) |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | HART RONALD W | Director | Buy | M | 0.40 | 21,522 | 8,609 | 711,060 | 689.5 K to 711.1 K (+3.12 %) |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | Bambot Shabbir Bakir | V.P.R & D | Option Exercise | A | 0.30 | 24,461 | 7,338 | 710,539 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Option Exercise | M | 0.40 | 125,869 | 50,348 | 0 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Option Exercise | A | 0.80 | 58,333 | 46,666 | 58,333 | |
| Jul 06 2012 | SPRX | GUIDED THERAPEUTIC ... | ALLEN RONALD W | Director | Option Exercise | A | 0.65 | 58,333 | 37,916 | 58,333 |